Ozempic manufacturer Novo Nordisk, as well as the manufacturer of other weight loss drugs Eli Lilly, are facing lawsuits from countless individuals who have developed severe side effects
It can also be prescribed off-label for weight loss if a person has a BMI of 30 or higher or a BMI of 27 or higher with a weight-related health condition, such as high blood pressure
Also, two open-label trials using 400 mg/day of riboflavin have decreased migraine attack frequency from 4 attacks per month to 2 attacks per month, and from 8.7 attacks per month to 2.9 attacks per month, respectively (100)
While the research is scanty, there is a lot of anecdotal evidence to back it up
[DOI] [PMC free article] [PubMed] [Google Scholar] 45.Stephens F.B., Wall B.T., Marimuthu K., Shannon C.E., Constantin-Teodosiu D., Macdonald I.A., Greenhaff P.L